Efficacy of a single oral dose of oxfendazole against Fasciola hepatica in naturally infected sheep
- PMID: 22403323
- PMCID: PMC3284368
- DOI: 10.4269/ajtmh.2012.11-0476
Efficacy of a single oral dose of oxfendazole against Fasciola hepatica in naturally infected sheep
Abstract
The efficacy of a single oral dose of 30 mg/kg of oxfendazole against Fasciola hepatica was evaluated in a controlled study in naturally infected sheep. Sheep were diagnosed by stool microscopy after sedimentation, and positive animals were randomized to oxfendazole (N = 20) or no treatment (N = 20). A new stool exam was performed 10 days after treatment. All stool microscopies were performed masked to the treatment group. No side effects were noticed. All sheep in the control group remained infected with similar counts of eggs per gram of stools. None of the animals in the treatment group showed Fasciola eggs in stools after 10 days of treatment. A single dose of oxfendazole is highly effective against F. hepatica, providing a new drug alternative for the control of fascioliasis or integrated zoonosis control.
Similar articles
-
Efficacy of triclabendazole against Fasciola hepatica in sheep and goats.Vet Parasitol. 1983 Sep;13(2):145-50. doi: 10.1016/0304-4017(83)90074-2. Vet Parasitol. 1983. PMID: 6685399
-
Assessment of flukicide efficacy against Fasciola hepatica in sheep in Sweden in the absence of a standardised test.Int J Parasitol Drugs Drug Resist. 2016 Dec;6(3):141-147. doi: 10.1016/j.ijpddr.2016.06.004. Epub 2016 Jun 26. Int J Parasitol Drugs Drug Resist. 2016. PMID: 27380550 Free PMC article.
-
Resistance of Fasciola hepatica against Triclabendazole in cattle in Cajamarca (Peru): a clinical trial and an in vivo efficacy test in sheep.Vet Parasitol. 2013 Jul 1;195(1-2):118-21. doi: 10.1016/j.vetpar.2013.01.001. Epub 2013 Jan 10. Vet Parasitol. 2013. PMID: 23352107 Clinical Trial.
-
A study of a restricted programme of strategic dosing against Fasciola hepatica with triclabendazole.Vet Rec. 1990 Nov 17;127(20):492-3. Vet Rec. 1990. PMID: 2275087
-
Resistance of Fasciola hepatica to triclabendazole.Aust Vet J. 1995 Jul;72(7):275-6. doi: 10.1111/j.1751-0813.1995.tb03546.x. Aust Vet J. 1995. PMID: 8534235 No abstract available.
Cited by
-
Anthelmintic effects of some medicinal plants on different life stages of Fasciola hepatica: Evidence on oxidative stress biomarkers, and DNA damage.PLoS Negl Trop Dis. 2024 Jun 17;18(6):e0012251. doi: 10.1371/journal.pntd.0012251. eCollection 2024 Jun. PLoS Negl Trop Dis. 2024. PMID: 38885188 Free PMC article.
-
Drug resistance in liver flukes.Int J Parasitol Drugs Drug Resist. 2020 Apr;12:39-59. doi: 10.1016/j.ijpddr.2019.11.003. Epub 2020 Jan 10. Int J Parasitol Drugs Drug Resist. 2020. PMID: 32179499 Free PMC article. Review.
-
Advancement in Diagnosis, Treatment, and Vaccines against Fasciola hepatica: A Comprehensive Review.Pathogens. 2024 Aug 7;13(8):669. doi: 10.3390/pathogens13080669. Pathogens. 2024. PMID: 39204269 Free PMC article. Review.
-
Screening the Pathogen Box for Identification of New Chemical Agents with Anti-Fasciola hepatica Activity.Antimicrob Agents Chemother. 2019 Feb 26;63(3):e02373-18. doi: 10.1128/AAC.02373-18. Print 2019 Mar. Antimicrob Agents Chemother. 2019. PMID: 30602522 Free PMC article.
-
New benzimidazole derivative compounds with in vitro fasciolicidal properties.Parasit Vectors. 2024 Apr 3;17(1):173. doi: 10.1186/s13071-024-06224-6. Parasit Vectors. 2024. PMID: 38570858 Free PMC article.
References
-
- Mas-Coma S, Valero MA, Bargues MD. Chapter 2. Fasciola, lymnaeids and human fascioliasis, with a global overview on disease transmission, epidemiology, evolutionary genetics, molecular epidemiology and control. Adv Parasitol. 2009;69:41–146. - PubMed
-
- Lean I, Westwood C, Playford M. Livestock disease threats associated with intensification of pastoral dairy farming. N Z Vet J. 2008;56:261–269. - PubMed
-
- Marcos LA, Terashima A, Leguia G, Canales M, Espinoza JR, Gotuzzo E. Fasciola hepatica infection in Peru: an emergent disease. Rev Gastroenterol Peru. 2007;27:389–396. - PubMed
-
- Espinoza JR, Terashima A, Herrera-Velit P, Marcos LA. Human and animal fascioliasis in Peru: impact in the economy of endemic zones. Rev Peru Med Exp Salud Publica. 2010;27:604–612. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources